Laser-fo­cused on col­orec­tal can­cer test, Freenome wins $160M from mar­quee VC pack led by RA, Po­laris

Days af­ter clos­ing RA Cap­i­tal’s new $300 mil­lion fund ded­i­cat­ed to biotech star­tups, Pe­ter Kochin­sky is tak­ing the wraps off a mega-round for can­cer de­tec­tion play­er Freenome.

RA Cap­i­tal, where he is man­ag­ing part­ner, has led the $160 mil­lion Se­ries B with Po­laris Part­ners, an in­vestor from the pri­or $65 mil­lion round. An­dreessen Horowitz, GV, Da­ta Col­lec­tive Ven­ture Cap­i­tal, Sec­tion 32 and Ver­i­ly all came back for more, while new mem­bers were added to the well-heeled syn­di­cate: Per­cep­tive Ad­vi­sors, Roche Ven­ture Fund, Kaiser Per­ma­nente Ven­tures and the Amer­i­can Can­cer So­ci­ety’s Bright­Edge Ven­tures, and T. Rowe Price As­so­ciates.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER